Literature DB >> 21457706

Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.

Abdulqader A Alhaider1, Hesham M Korashy, Mohamed M Sayed-Ahmed, Mohammed Mobark, Hala Kfoury, Mahmoud A Mansour.   

Abstract

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion and/or action. One of the most important complications of this metabolic disease is diabetic nephropathy. Hyperglycemia promotes oxidative stress and hence generation of reactive oxygen species (ROS), which is known to play a crucial role in the pathogenesis of diabetic nephropathy. Recent studies have established that metformin, an oral hypoglycemic drug, possesses antioxidant effects. However, whether metformin can protect against diabetic nephropathy has not been reported before. The overall objectives of the present study are to elucidate the potential nephroprotective effect of metformin in a rat diabetic nephropathy model and explore the exact underlying mechanism(s) involved. The effect of metformin on the biochemical changes associated with hyperglycemia induced by streptozotocin was investigated in rat kidney tissues. In addition, energy nucleotides (AMP and ATP), and Acetyl-CoA in the kidney homogenates and mitochondria, and the mRNA expression of oxidative stress and pro-inflammatory mediators were assessed. Our results showed that treatment of normoglycemic rats with metformin caused significant increase in ATP, Acetyl-CoA, and CoA-SH contents in kidney homogenates and mitochondria along with profound decrease in AMP level. On the other hand, treatment of diabetic nephropathy rats with metformin normalized all biochemical changes and the energy status in kidney tissues. At the transcriptional levels, metformin treatment caused significant restoration in diabetic nephropathy-induced oxidative stress mRNA levels, particularly GSTα, NQO1, and CAT genes, whereas inhibited TNF-α and IL-6 pro-inflammatory genes. Our data lend further credence for the contribution of metformin in the nephroprotective effect in addition to its well known hypoglycemic action.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21457706     DOI: 10.1016/j.cbi.2011.03.014

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  53 in total

1.  Role of adenylyl cyclase activator in controlling experimental diabetic nephropathy in rats.

Authors:  Lakhwinder Singh; Surbhi Rana; Sidharth Mehan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-10-29

2.  Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: Evaluation via biochemical markers and color Doppler ultrasonography.

Authors:  Peifeng Dai; Junhua Wang; Lin Lin; Yanyan Zhang; Zhengping Wang
Journal:  Exp Ther Med       Date:  2015-06-22       Impact factor: 2.447

3.  Effects of the Nrf2 Protein Modulator Salvianolic Acid A Alone or Combined with Metformin on Diabetes-associated Macrovascular and Renal Injury.

Authors:  Ping Wu; Yu Yan; Lin-Lin Ma; Bi-Yu Hou; Yang-Yang He; Li Zhang; Zi-Ran Niu; Jun-Ke Song; Xiao-Cong Pang; Xiu-Ying Yang; Guan-Hua Du
Journal:  J Biol Chem       Date:  2016-07-14       Impact factor: 5.157

Review 4.  Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

Authors:  Milton Packer
Journal:  J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 10.121

5.  The 5'-AMP-Activated Protein Kinase (AMPK) Is Involved in the Augmentation of Antioxidant Defenses in Cryopreserved Chicken Sperm.

Authors:  Thi Mong Diep Nguyen; François Seigneurin; Pascal Froment; Yves Combarnous; Elisabeth Blesbois
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

6.  Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein.

Authors:  Ting Zhang; Xiaorong Hu; Yuli Cai; Bo Yi; Zhongyuan Wen
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

7.  Ethanol extract of mango (Mangifera indica L.) peel inhibits α-amylase and α-glucosidase activities, and ameliorates diabetes related biochemical parameters in streptozotocin (STZ)-induced diabetic rats.

Authors:  Mahendranath Gondi; U J S Prasada Rao
Journal:  J Food Sci Technol       Date:  2015-07-29       Impact factor: 2.701

Review 8.  Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Authors:  Runa Lindblom; Gavin Higgins; Melinda Coughlan; Judy B de Haan
Journal:  Rev Diabet Stud       Date:  2015-08-10

9.  Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.

Authors:  Michael D Wetzel; Ting Gao; Kristen Stanley; Timothy K Cooper; Sidney M Morris; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-06

10.  The protective effect of metformin against the noise-induced hearing loss.

Authors:  Gülin Gökçen Kesici; Fatma Ceyda Akın Öcal; Seren Gülşen Gürgen; Şaban Remzi Erdem; Ersin Öğüş; Hatice Seyra Erbek; Levent Naci Özlüoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-10       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.